$AMP

AMP Looks 5.3% Undervalued on GF Value™

Ameriprise Financial (AMP) announced a partnership with Hamilton Lane to launch a new growth equity fund. AMP is trading at $557.31, 5.3% below its GF Value™ of $588.38, suggesting undervaluation. The company has a GF Score™ of 88/100, with strong growth and momentum ratings. Insiders have sold $65.9M in shares over the past year, while institutional gurus show strong interest.

Original reporting
Published Sep 15, 2026, 2:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 4:59 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AMP
Neutral
medium confidence
Mentioned
$AMP
Relevance
5/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$AMPNeutralLow
01

Why it matters

The new Columbia Hamilton Lane Growth Innovation Fund aims to blend public and private equity, potentially increasing AMP's AUM and fee revenue.

02

Market read

A strategic partnership that could enhance AMP's product offering, but immediate price impact is modest.

03

What to watch

Regulatory approval timeline for the interval fund and potential competition from other private‑market platforms.

Relevance 5/10Novelty 5/10Timing: September 15, 2026 announcement

Background

AMP (Ameriprise Financial) is a diversified financial services firm with a $49.23 B market cap, focusing on wealth management and asset management.

Company-level read

Ticker impact

$AMPNeutralMedium confidence
Context

AMP announced a strategic partnership with Hamilton Lane to launch a new growth equity interval fund, a fresh corporate development.

Expected impact

Modest upside if the fund receives strong advisor adoption; limited downside risk.

Evidence & confidence

New collaboration adds growth potential but lacks immediate financial metrics; impact depends on fund launch execution.

Market effects

May boost the asset‑management sector as firms seek private‑market exposure.

Primarily U.S. wealth‑management market; limited global ripple.

Low, confined to AMP and its advisors.

Counterpoint

The partnership could distract management from core operations and delay earnings improvements.

Key entities

  • Ameriprise Financial Inc.

    Parent company of AMP, providing the partnership framework.

  • Hamilton Lane

    Private‑markets specialist partnering with AMP.

Related articles

$AMPHighAI 8/10

Ameriprise Financial Stock: Analyst Estimates & Ratings

Ameriprise Financial (AMP) reported Q2 2026 revenue of $4.9B, up 15.6% YoY, and adjusted EPS of $11.07, beating estimates. Analysts expect 17.6% EPS growth for the year. The stock has risen 14.3% in 2026, outperforming the S&P 500. Analysts rate it 'Moderate Buy' with a mean price target of $582.54, implying 4% upside.

$AMPMed

AMP (ASX:AMP) Is Up 12.6% After Strong Half-Year Profit Lift - What's Changed

AMP Limited reported half-year results to 30 June 2026, with revenue up to A$1,425 million and net income to A$154 million. Basic EPS from continuing operations rose to A$0.061. The article links the profit lift to efficiency and business mix changes, notes margin and cost risks, and mentions Richard Millington’s appointment to lead Employer Adviser Partnerships.

$AMPMed

AMP Shares At Highest Level In Years, Lead ASX 200 Gainers

AMP Ltd shares (ASX:AMP) rose 5.96% to A$2.31, near a 2018 high, after its half-year 2026 results. Assets under management grew 8.2% to $167.6B. Platforms net cash flows rose 33% to $3.1B, and Superannuation net inflows were $76M. Underlying NPAT rose 33% to $174M. Interim dividend was 3c (20% franked) and AMP plans a $150M buyback.

$AMPMedAI 8/10

Why is AMP stock surging today?

AMP shares rose 6% to a seven-year high of A$2.31 after the company reported a strong half-year. Underlying net profit after tax rose 33% to AUD 174 million, beating analyst consensus of about AUD 142 million and the company’s AUD 170–180 million guidance. Statutory NPAT rose 57% to AUD 154 million. AMP also announced a AUD 150 million buyback and raised its dividend payout ratio to 41% from 35%.

$AMPMed

AMP H1 profit jumps 57% on China partnerships, wealth gains

AMP Limited reported a 57% rise in half-year net profit to A$154 million for the six months ended June 30, driven by stronger China partnerships and wealth platforms that offset weaker banking. Revenue rose 4% to A$1.425 billion. Underlying profit increased 32.8% to A$174 million. The board declared a 3.0c interim dividend and approved an additional on-market buyback tranche up to A$150 million.